Paper21069451
Aberrant expression of DNA damage response proteins is associated with breast cancer subtype and clinical features.
Guler G and 13 others. Breast Cancer Res Treat, 2011. Cited by 44 papers, by iCite.
Cite this record
ConductScience Library. Aberrant expression of DNA damage response proteins is associated with breast cancer subtype and clinical features. Papers, record 21069451. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21069451
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics32
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Cell Cycle Proteins | Major topic |
| DNA Damage | Major topic |
| Acid Anhydride Hydrolases | |
| Adult | |
| BRCA1 Protein | |
| Checkpoint Kinase 2 | |
| Chi-Square Distribution | |
| Disease-Free Survival | |
| ErbB Receptors | |
| Female | |
| Histones | |
| Humans | |
| Immunohistochemistry | |
| Kaplan-Meier Estimate | |
| Logistic Models | |
| Middle Aged | |
| Neoplasm Proteins | |
| Odds Ratio | |
| Oxidoreductases | |
| Prognosis | |
| Proportional Hazards Models | |
| Protein Serine-Threonine Kinases | |
| Receptor, ErbB-4 | |
| Survival Analysis | |
| Time Factors | |
| Tissue Array Analysis | |
| Transcription Factor AP-2 | |
| Tumor Suppressor Protein p53 | |
| Tumor Suppressor Proteins | |
| WW Domain-Containing Oxidoreductase | |
| Bis(5'-adenosyl)triphosphatase |
Source PubMed
Grants6
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| CA115965 | NCI NIH HHS | United States | R01CA115965 | PubMed and NIH | NIH RePORTER |
| CA120516 | NCI NIH HHS | United States | R01CA120516 | PubMed and NIH | NIH RePORTER |
| CA132453 | NCI NIH HHS | United States | R01CA132453 | PubMed and NIH | NIH RePORTER |
| R01 CA132453 | NCI NIH HHS | United States | R01CA132453 | PubMed and NIH | NIH RePORTER |
| R01 CA120516 | NCI NIH HHS | United States | R01CA120516 | PubMed and NIH | NIH RePORTER |
| R01 CA115965 | NCI NIH HHS | United States | R01CA115965 | PubMed and NIH | NIH RePORTER |
References46
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12124341 | The fragile histidine triad/common chromosome fragile site 3B locus and repair-deficient cancers. | Cancer Res | 2002 | https://conductscience.org/library/papers/12124341 | PubMed |
| 2 | 18454307 | Role of ErbB4 in breast cancer. | J Mammary Gland Biol Neoplasia | 2008 | https://conductscience.org/library/papers/18454307 | PubMed |
| 3 | 19957554 | [Effect of WWOX gene on the attachment and adhesion of ovarian cancer cells]. | Zhonghua Fu Chan Ke Za Zhi | 2009 | https://conductscience.org/library/papers/19957554 | PubMed |
| 4 | 19775601 | Clinical relevance of the triple-negative breast cancer concept: genetic basis and clinical utility of the concept. | Eur J Cancer | 2009 | https://conductscience.org/library/papers/19775601 | PubMed |
| 5 | 15223047 | Breast cancer, stem/progenitor cells and the estrogen receptor. | Trends Endocrinol Metab | 2004 | https://conductscience.org/library/papers/15223047 | PubMed |
| 6 | 15549093 | Cell-cycle checkpoints and cancer. | Nature | 2004 | https://conductscience.org/library/papers/15549093 | PubMed |
| 7 | 15829967 | Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. | Nature | 2005 | https://conductscience.org/library/papers/15829967 | PubMed |
| 8 | 19553641 | Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. | N Engl J Med | 2009 | https://conductscience.org/library/papers/19553641 | PubMed |
| 9 | 15073846 | The fragile genes FHIT and WWOX are inactivated coordinately in invasive breast carcinoma. | Cancer | 2004 | https://conductscience.org/library/papers/15073846 | PubMed |
| 10 | 19351835 | Defective repair of oxidative dna damage in triple-negative breast cancer confers sensitivity to inhibition of poly(ADP-ribose) polymerase. | Cancer Res | 2009 | https://conductscience.org/library/papers/19351835 | PubMed |
| 11 | 16936829 | GammaH2AX and its role in DNA double-strand break repair. | Biochem Cell Biol | 2006 | https://conductscience.org/library/papers/16936829 | PubMed |
| 12 | 20459590 | Emergence of rationally designed therapeutic strategies for breast cancer targeting DNA repair mechanisms. | Breast Cancer Res | 2010 | https://conductscience.org/library/papers/20459590 | PubMed |
| 13 | 18483248 | Fhit-deficient hematopoietic stem cells survive hydroquinone exposure carrying precancerous changes. | Cancer Res | 2008 | https://conductscience.org/library/papers/18483248 | PubMed |
| 14 | 18316557 | Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype. | Clin Cancer Res | 2008 | https://conductscience.org/library/papers/18316557 | PubMed |
| 15 | 16522651 | BRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution. | Nucleic Acids Res | 2006 | https://conductscience.org/library/papers/16522651 | PubMed |
| 16 | 17909041 | Association of Wwox with ErbB4 in breast cancer. | Cancer Res | 2007 | https://conductscience.org/library/papers/17909041 | PubMed |
| 17 | 9823304 | Loss of FHIT function in lung cancer and preinvasive bronchial lesions. | Cancer Res | 1998 | https://conductscience.org/library/papers/9823304 | PubMed |
| 18 | 19086848 | Fhit tumor suppressor: guardian of the preneoplastic genome. | Future Oncol | 2008 | https://conductscience.org/library/papers/19086848 | PubMed |
| 19 | 15829965 | Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. | Nature | 2005 | https://conductscience.org/library/papers/15829965 | PubMed |
| 20 | 18084328 | Oncogene-induced replication stress preferentially targets common fragile sites in preneoplastic lesions. A genome-wide study. | Oncogene | 2008 | https://conductscience.org/library/papers/18084328 | PubMed |
Cited by30
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 44 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41677473 | Weight Loss Patterns and Clinical Outcomes of GLP1 Receptor Agonists in Breast Cancer Survivors. | Cancer Res Commun | 2026 | https://conductscience.org/library/papers/41677473 | PubMed |
| 41476672 | The Landscape of Potential Targeted Treatments and Chemotherapy Efficacy Biomarkers for TNBC. | Breast Cancer (Dove Med Press) | 2025 | https://conductscience.org/library/papers/41476672 | PubMed |
| 38499540 | Unveiling the relationship between WWOX and BRCA1 in mammary tumorigenicity and in DNA repair pathway selection. | Cell Death Discov | 2024 | https://conductscience.org/library/papers/38499540 | PubMed |
| 35409089 | Wwox Binding to the Murine Brca1-BRCT Domain Regulates Timing of Brip1 and CtIP Phospho-Protein Interactions with This Domain at DNA Double-Strand Breaks, and Repair Pathway Choice. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35409089 | PubMed |
| 33946771 | Molecular Functions of WWOX Potentially Involved in Cancer Development. | Cells | 2021 | https://conductscience.org/library/papers/33946771 | PubMed |
| 31938155 | Correlation of expression of WWOX and JNK with clinicopathologic features in human breast carcinoma. | Int J Clin Exp Pathol | 2018 | https://conductscience.org/library/papers/31938155 | PubMed |
| 31419716 | Metallic air pollutants and breast cancer heterogeneity. | Environ Res | 2019 | https://conductscience.org/library/papers/31419716 | PubMed |
| 30370248 | Modeling WWOX Loss of Function in vivo: What Have We Learned? | Front Oncol | 2018 | https://conductscience.org/library/papers/30370248 | PubMed |
| 30211123 | WWOX Tumor Suppressor Gene in Breast Cancer, a Historical Perspective and Future Directions. | Front Oncol | 2018 | https://conductscience.org/library/papers/30211123 | PubMed |
| 30158849 | WWOX Phosphorylation, Signaling, and Role in Neurodegeneration. | Front Neurosci | 2018 | https://conductscience.org/library/papers/30158849 | PubMed |
| 30154439 | Loss of Wwox drives metastasis in triple-negative breast cancer by JAK2/STAT3 axis. | Nat Commun | 2018 | https://conductscience.org/library/papers/30154439 | PubMed |
| 30082886 | Somatic loss of WWOX is associated with TP53 perturbation in basal-like breast cancer. | Cell Death Dis | 2018 | https://conductscience.org/library/papers/30082886 | PubMed |
| 27801830 | The Expression and Clinical Outcome of pCHK2-Thr68 and pCDC25C-Ser216 in Breast Cancer. | Int J Mol Sci | 2016 | https://conductscience.org/library/papers/27801830 | PubMed |
| 27769050 | Protein phosphatase Mg2+/Mn2+ dependent 1F promotes smoking-induced breast cancer by inactivating phosphorylated-p53-induced signals. | Oncotarget | 2016 | https://conductscience.org/library/papers/27769050 | PubMed |
| 27006338 | Chronic oxidative stress promotes H2AX protein degradation and enhances chemosensitivity in breast cancer patients. | EMBO Mol Med | 2016 | https://conductscience.org/library/papers/27006338 | PubMed |
| 26485712 | High Levels of Nucleolar Spindle-Associated Protein and Reduced Levels of BRCA1 Expression Predict Poor Prognosis in Triple-Negative Breast Cancer. | PLoS One | 2015 | https://conductscience.org/library/papers/26485712 | PubMed |
| 25965342 | A Synthetic Lethal Screen Identifies DNA Repair Pathways that Sensitize Cancer Cells to Combined ATR Inhibition and Cisplatin Treatments. | PLoS One | 2015 | https://conductscience.org/library/papers/25965342 | PubMed |
| 25779666 | Fatty acid binding protein 5 promotes metastatic potential of triple negative breast cancer cells through enhancing epidermal growth factor receptor stability. | Oncotarget | 2015 | https://conductscience.org/library/papers/25779666 | PubMed |
| 25681467 | Alteration of WWOX in human cancer: a clinical view. | Exp Biol Med (Maywood) | 2015 | https://conductscience.org/library/papers/25681467 | PubMed |
| 25538133 | WWOX: a fragile tumor suppressor. | Exp Biol Med (Maywood) | 2015 | https://conductscience.org/library/papers/25538133 | PubMed |
Genes22
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/21069451
GET https://conductscience.org/api/papers/v1/21069451/references?page=2